News | Clinical Decision Support | November 17, 2016

For every attendee that takes part in a demonstration of its Quantitative Imaging Decision Support platform, HealthMyne will donate $25 to Madison, Wis. charity supporting cancer patients and their families

November 17, 2016 — HealthMyne has partnered with Gilda’s Club of Madison (Wis.) in an effort to make a difference in the lives of children and adults living with cancer during the 2016 Radiological Society of North America (RSNA) annual meeting.

For each RSNA attendee that takes part in a demo of HealthMyne’s Quantitative Imaging Decision Support (QIDS) software platform, the company will make a $25 donation to Gilda’s. Gilda’s offers support for those with cancer, but it also provides support for the entire family throughout their entire journey. This includes support groups, lectures, workshops and a variety of social events. Those attendees that take part will have an opportunity to sign their name to the “Donation Board” and get an “I Donated” sticker to proudly display their kind deed.

The QIDS platform combines imaging data with electronic medical record, radiation therapy and other clinical systems information to provide clinical decision support in the primary read. Currently focused on radiology and oncology, with future expansion into other specialties, QIDS (pronounced ‘quids’) is designed to positively impact clinical productivity and prepares radiologists for the transition to value-based payment.

HealthMyne asserts that in order for radiologists to extend their value as a member of the care team, highly curated evidence-based narratives, imaging analytics and patient cohort analysis must be generated to provide clinical decision support in the primary read, thereby enabling improved cancer diagnosis, staging and treatment.

For more information: www.healthmyne.com


Related Content

News | Radiology Business

May 22, 2024 — Medtronic has announced new preliminary data from the VERITAS clinical study using its ILLUMISITE ...

Time May 22, 2024
arrow
News | FDA

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

Time March 06, 2024
arrow
News | FDA

February 12, 2024 — Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) ...

Time February 12, 2024
arrow
News | Artificial Intelligence

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

Time September 20, 2023
arrow
News | SNMMI

June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) ...

Time June 29, 2023
arrow
News | Digital Pathology

September 13, 2022 — Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has ...

Time September 13, 2022
arrow
Feature | Artificial Intelligence | By Dave Fornell, ITN Editor

Artificial intelligence (AI) has found a unique niche to help automate the activation of acute care teams for pulmonary ...

Time January 19, 2022
arrow
Feature | Enterprise Imaging

Taking advantage of new technology advances, several radiology PACS, enterprise imaging and cardiovascular information ...

Time November 04, 2021
arrow
Videos | Information Technology

David Danhauer, M.D., FAAP, FHIMSS, chief medical information officer, Owensboro Health, Owensboro, Ky., explains the ...

Time August 30, 2021
arrow
Videos | Enterprise Imaging

Alex Towbin, M.D., Cincinnati Children’s Hospital Medical Center CMIO, Radiology Department associate chief of clinical ...

Time August 27, 2021
arrow
Subscribe Now